Recent research has begun to explore the use of GLP-1 receptor agonists in treating various mental health conditions, including addiction and binge eating disorder
Statements Author contributions MS and MK conceived and designed the study
Currently, only two novel are under development: amycretin - GLP-1/ amylin coagonist, and VK2735 GLP-1/GIP receptor coagonist
doi: 10.1111/dom.13484 2 BethelM
Clearly quality professionals, regulatory bodies such as FDA, members of the judicial system, and even consumers
Along with Lactoferrin and Immunoglobulins, this type of protein contains cysteine and glutamine, precursors in glutathione (GSH) production